Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Evaluation of Outpatient Prescription Patterns of Covid-19 Drugs in Iran: Comparison of Real Practice With Local Therapeutic Recommendations Publisher



Zargarzadeh AH1 ; Abdi Z2 ; Mousavi S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Hezar Jerib Avenue, Isfahan, Iran
  2. 2. School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Pharmaceutical Policy and Practice Published:2023


Abstract

Background: A comprehensive guideline named “Diagnostic Therapeutic Flow Chart for Covid-19″ (DTFC) was released by the Scientific Committee of Covid-19 of Iran’s Ministry of Health and Medical Education and regularly was updated. The aim of this study was to compare the prescription pattern of drug treatment in outpatient Covid-19 patients with the DTFC. Methods: A cross-sectional study was conducted on the prescription pattern of drugs given to outpatients with a diagnosis of Covid-19, in Isfahan City from June to September 2021 (concurrent with the fifth peak of Covid-19 in Iran) taking into account the recommendations of the 9th version of DTFC (December 2020). A total of 8250 prescriptions were retrieved from the Public Health Department of Isfahan City. Results: Famotidine 20, 40 mg tablets (N = 936 patients) was the most prescribed drug followed by dexamethasone ampule (N = 588), prednisolone 5, 50 mg tablets (N = 478), azithromycin 250, 500 mg capsules (N = 452), diphenhydramine syrup (N = 362), vitamin D3 soft gel 50,000 Iu (N = 526), naproxen 250, 500 mg tablets (N = 266) and favipiravir 200 mg tablet (N = 191). The following drugs were administered against the recommendation of the DTFC-9: azithromycin, favipiravir, remdesivir, cetirizine, corticosteroids, vitamin C, vitamin B12, multivitamins, proton pump inhibitors (e.g., omperazole, anticoagulants (rivaroxaban,….), aspirin and ivermectin. Administration of analgesics, famotidine, hydroxychloroquine, vitamin D3, diphenhydramine and statins were in concordance with the DTFC-9. Conclusion: In this study, we showed frequent use of drugs with unproven efficacy in outpatient cases of Covid-19 mostly attributed to corticosteroids and antibiotics use. Our research highlights the discrepancy between recommendations for care and clinical practice and the need for strategy to bridge gaps in evidence-based informed decision-making. © 2023, The Author(s).
Related Docs
View other Related Docs
1. Efficacy of Persian Medicine Herbal Formulations (Capsules And Decoction) Compared to Standard Care in Patients With Covid-19, a Multicenter Open-Labeled, Randomized, Controlled Clinical Trial, Phytotherapy Research (2021)
2. Epidemiological Status and Health System Screening of Covid 19 Hospitalized Patients in Isfahan, Iran, Medical Journal of the Islamic Republic of Iran (2022)
3. Intravenous Methylprednisolone Pulse As a Treatment for Hospitalised Severe Covid-19 Patients: Results From a Randomised Controlled Clinical Trial, European Respiratory Journal (2020)
4. Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies, Journal of Experimental and Clinical Medicine (Turkey) (2022)
5. Surveillance of Antibiotic Consumption Point Prevalence Survey 2014: Antimicrobial Prescribing in Pediatrics Wards of 16 Iranian Hospitals, Archives of Iranian Medicine (2016)
6. Treatment of Covid-19 With Pentoxifylline: Could It Be a Potential Adjuvant Therapy?, Dermatologic Therapy (2020)
7. Clinical, Laboratory and Imaging Characteristics, and Outcomes of Hospitalized Children With Suspected Covid-19 Infection: A Report From Isfahan-Iran, Journal of Research in Medical Sciences (2022)
8. Asymptomatic Carriers of Coronavirus Disease 2019 Among Healthcare Workers in Isfahan, Iran, Future Virology (2021)
Experts (# of related papers)
View all Related Experts
Ramin Sami (6)
Shaghayegh Haghjooy Javanmard (5)
Other Related Docs
9. Multivariable Analysis of Clinical and Laboratory Data Manifestations Predicting Severity and Mortality Risk in Patients With Coronavirus Disease 2019 in the Mountainous West of Iran: A Retrospective Single-Center Study, Asian Biomedicine (2022)
10. Infliximab and Intravenous Gammaglobulin in Hospitalized Severe Covid-19 Patients in Intensive Care Unit, Archives of Iranian Medicine (2021)
11. Favipiravir in the Treatment of Outpatient Covid-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial, Advances in Respiratory Medicine (2023)
12. The Influence of Propolis Plus Hyoscyamus Niger L. Against Covid-19: A Phase Ii, Multicenter, Placebo-Controlled, Randomized Trial, Phytotherapy Research (2024)
13. Risk Factors of Covid-19 Associated Mucormycosis in Iranian Patients: A Multicenter Study, BMC Infectious Diseases (2024)
14. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
15. Evaluation of the Factors Associated With Prescribed and Non-Prescribed Medicine: A Population-Based Study, Current Drug Safety (2023)
16. A Study on the Effect of Aspirin on Clinical Symptoms, Laboratory Indices, and Outcomes in Patients With Covid-19, Journal of Nephropharmacology (2023)
17. Evaluation of the Effect of Montelukast Drug in Improving the Clinical Condition of Patients With Covid-19 in Referral Hospitals in Isfahan; a Randomized Clinical Trial, Journal of Nephropharmacology (2024)
18. Electrolyte Abnormalities in Hospitalized Covid-19 Patients at Tertiary Referral Centers in Tehran: Hypermagnesemia As a Marker of Fatality: A Retrospective Cross-Sectional Study, Health Science Reports (2023)
19. Risk Factors, Clinical, and Laboratory Characteristics of Patients With a Diagnosis of Covid-19, Journal of Emergency Practice and Trauma (2022)
20. Age-Dependent Clinical Features and Prognosis of Covid-19 Patients, Tanaffos (2021)
21. Lactate Dehydrogenase to Albumin Ratio As a Predictive Factor of Covid-19 Patients’ Outcome; a Cross-Sectional Study, Archives of Academic Emergency Medicine (2022)
22. Effect of Curcumin-Pipeine Supplementation on Clinical Status, Mortality Rate, Oxidative Stress, and Inflammatory Markers in Critically Ill Icu Patients With Covid-19: A Structured Summary of a Study Protocol for a Randomized Controlled Trial, Trials (2021)
23. Use of Complementary and Alternative Medicine in General Population During Covid-19 Outbreak: A Survey in Iran, Journal of Integrative Medicine (2022)
24. The Covid-19 Pandemic: A Systematic Review of the Current Evidence; [Пандемия Covid-19: Систематический Обзор Современных Данных], Russian Journal of Infection and Immunity (2020)
25. The Severity of Symptoms and Outcomes of Patients Admitted With Rheumatic Diseases and Covid-19; a Prospective Cohort Study in Iran, Immunopathologia Persa (2021)
26. Medical Evaluation of Test Results Related to Covid 19 in Iranian Hospitals Using Quadas-2 to Evaluate the Quality of Studies and Meta-Analysis Using Stata / Mp V.16 Software, Journal of Medicinal and Chemical Sciences (2022)
27. Sex Differences in the Relation Between Comorbidities and Prognosis in Hospitalized Patients With Covid-19, Interdisciplinary Perspectives on Infectious Diseases (2022)
28. Risk Factors Associated With Severity and Death From Covid-19 in Iran: A Systematic Review and Meta-Analysis Study, Journal of Intensive Care Medicine (2023)
29. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
30. Covid-19, an Early Investigation From Exposure to Treatment Outcomes in Tehran, Iran, Journal of Research in Medical Sciences (2021)
31. Efficacy of Hydroxychloroquine in Pre-Exposure Severe Acute Respiratory Syndrome Coronavirus 2 Prophylaxis Among High-Risk Healthcare Workers: A Multicenter Study, Advanced Biomedical Research (2023)
32. Isfahan Covid Cohort Study: Rationale, Methodology, and Initial Results, Journal of Research in Medical Sciences (2022)
33. Opium and Tobacco Use, and Outcome in Covid-19 Infected Patients: A Cross-Sectional Study, International Journal of High Risk Behaviors and Addiction (2024)
34. A Complementary Critical Appraisal on Systematic Reviews Regarding the Most Efficient Therapeutic Strategies for the Current Covid-19 (Sars-Cov-2) Pandemic, Journal of Medical Virology (2021)
35. Effect of Multiple Sclerosis Disease-Modifying Therapies on the Real-World Effectiveness of Two Doses of Bbibp-Corv (Sinopharm) Vaccine, Journal of the Neurological Sciences (2023)
36. Epidemiological Features of Covid-19 in Iran, Journal of Research in Medical Sciences (2022)
37. C-Reactive Protein, D-Dimer, Erythrocyte Sedimentation Rate, and Troponin in Intensive Care Unit Patients With Covid-19 in Iran, Journal of Research in Medical Sciences (2023)
38. Covid-19 Infection and Hospitalization Rate in Iranian Multiple Sclerosis Patients: What We Know by May 2021, Multiple Sclerosis and Related Disorders (2022)
39. Survey of Coronary Catheterization Laboratory Activity in Iran During the Coronavirus Disease-2019 Pandemic, ARYA Atherosclerosis (2021)
40. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
41. Evidence-Based Prediction of Covid-19 Severity in Hospitalized Children, International journal of clinical practice (2022)
42. Factors Related to the Hospital Admissions of Covid-19 Patients in the Intensive Care Unit of Selected Iranian Navy Hospitals, Iranian Journal of War and Public Health (2021)
43. Antibiotic Use During the First 6 Months of Covid-19 Pandemic in Iran: A Large-Scale Multi-Centre Study, Journal of Clinical Pharmacy and Therapeutics (2022)
44. Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study, Journal of Nephropharmacology (2023)
45. The Effect of Propolis Supplementation on Clinical Symptoms in Patients With Coronavirus (Covid-19): A Structured Summary of a Study Protocol for a Randomised Controlled Trial, Trials (2020)
46. Effect of Covid-19 Medications on Corrected Qt Interval and Induction of Torsade De Pointes: Results of a Multicenter National Survey, International Journal of Clinical Practice (2021)
47. Investigating Methods for Coronavirus Disease 2019 Control: A Systematic Review, Polish Annals of Medicine (2021)
48. The Effect of Vitamin E and Vitamin C in Patients With Covid-19 Pneumonia; a Randomized Controlled Clinical Trial, Immunopathologia Persa (2022)
49. Effects of Curcumin-Piperine Co-Supplementation on Clinical Signs, Duration, Severity, and Inflammatory Factors in Patients With Covid-19: A Structured Summary of a Study Protocol for a Randomised Controlled Trial, Trials (2020)
50. Comparison of the Effect of Intravenous Dexamethasone and Methylprednisolone on the Treatment of Hospitalized Patients With Covid-19: A Randomized Clinical Trial, International Journal of Infectious Diseases (2022)